ImmunityBio

immunitybio layoffs california florida, immunitybio anktiva fda rejection, immunitybio bladder cancer drug cll, immunitybio contract manufacturing issues, immunitybio cost reduction strategy, immunitybio anktiva approval status, immunitybio bladder cancer market

ImmunityBio cuts 50 jobs in California and Florida after FDA snubs its bladder cancer drug

Anika Sharma

Following an FDA rejection earlier this year, ImmunityBio has initiated its second round of layoffs in less than a year, ...